Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...

The median follow-up of 37 months showed that PSMAiSRT improved FFS and eugonadal FFS, with significant improvements in the ...

These 10-year results confirm that hypofractionated radiotherapy (68 Gy in 25 fractions) is non-inferior to conventionally fractionated radiotherapy (76 Gy in 38 fractions) for high-risk prostate ...

ASTRO 2025: Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy ...

A radiotherapy regime involving higher doses of radiation is a better option than having lower doses for men with localised prostate cancer, the 10-year results of the largest trial of its kind have ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

Share on Pinterest A new trial is exploring an androgen receptor blocker in treating prostate cancer. FG Trade/Getty Images A second-generation androgen receptor blocker added to other prostate cancer ...

A shorter course of radiotherapy, administered through fewer, higher intensity doses, is as well tolerated over five years as longer treatment courses for treating prostate cancer, long-term results ...

David Kok has a clinical appointment at Peter MacCallum Cancer Centre which provides prostate cancer treatments including stereotactic radiotherapy, conventional radiotherapy and surgery. Sathana ...